Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Intervalo de año de publicación
1.
Braz J Med Biol Res ; 51(9): e7552, 2018 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-29972429

RESUMEN

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Asunto(s)
Antioxidantes/farmacología , Caenorhabditis elegans/efectos de los fármacos , Paullinia/química , Extractos Vegetales/farmacología , Envejecimiento/efectos de los fármacos , Animales , Antioxidantes/aislamiento & purificación , Caenorhabditis elegans/fisiología , Longevidad/efectos de los fármacos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo
2.
Braz. j. med. biol. res ; 51(9): e7552, 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-951753

RESUMEN

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Asunto(s)
Animales , Extractos Vegetales/farmacología , Caenorhabditis elegans/efectos de los fármacos , Paullinia/química , Antioxidantes/farmacología , Factores de Tiempo , Envejecimiento/efectos de los fármacos , Caenorhabditis elegans/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Longevidad/efectos de los fármacos , Antioxidantes/aislamiento & purificación
3.
Braz J Med Biol Res ; 49(9): e5235, 2016 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-27533765

RESUMEN

Improving overall health and quality of life, preventing diseases and increasing life expectancy are key concerns in the field of public health. The search for antioxidants that can inhibit oxidative damage in cells has received a lot of attention. Rosmarinus officinalis L. represents an exceptionally rich source of bioactive compounds with pharmacological properties. In the present study, we explored the effects of the ethanolic extract of R. officinalis (eeRo) on stress resistance and longevity using the non-parasitic nematode Caenorhabditis elegans as a model. We report for the first time that eeRo increased resistance against oxidative and thermal stress and extended C. elegans longevity in an insulin/IGF signaling pathway-dependent manner. These data emphasize the eeRo beneficial effects on C. elegans under stress.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Longevidad/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Rosmarinus/química , Estrés Fisiológico/efectos de los fármacos , Animales , Proteínas de Caenorhabditis elegans/efectos de los fármacos , Proteínas de Unión al ADN/efectos de los fármacos , Factores de Transcripción Forkhead/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/efectos de los fármacos
4.
Braz. j. med. biol. res ; 49(9): e5235, 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-788945

RESUMEN

Improving overall health and quality of life, preventing diseases and increasing life expectancy are key concerns in the field of public health. The search for antioxidants that can inhibit oxidative damage in cells has received a lot of attention. Rosmarinus officinalis L. represents an exceptionally rich source of bioactive compounds with pharmacological properties. In the present study, we explored the effects of the ethanolic extract of R. officinalis (eeRo) on stress resistance and longevity using the non-parasitic nematode Caenorhabditis elegans as a model. We report for the first time that eeRo increased resistance against oxidative and thermal stress and extended C. elegans longevity in an insulin/IGF signaling pathway-dependent manner. These data emphasize the eeRo beneficial effects on C. elegans under stress.


Asunto(s)
Animales , Caenorhabditis elegans/efectos de los fármacos , Longevidad/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Rosmarinus/química , Estrés Fisiológico/efectos de los fármacos , Proteínas de Caenorhabditis elegans/efectos de los fármacos , Proteínas de Unión al ADN/efectos de los fármacos , Factores de Transcripción Forkhead/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/efectos de los fármacos
5.
Neuroscience ; 278: 40-50, 2014 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-25130558

RESUMEN

Alzheimer's disease (AD) is the most common and devastating neurodegenerative disease. The etiology of AD has yet to be fully understood, and common treatments remain largely non-efficacious. The amyloid hypothesis posits that extracellular amyloid-ß (Aß) deposits are the fundamental etiological factor of the disease. The present study tested the organoselenium compound diphenyl-diselenide (PhSe)2, which is characterized by its antioxidant and antiinflammatory properties and has shown efficacy in several neurodegenerative disease models. We employed a transgenic Caenorhabditis elegans AD model to analyze the effects of (PhSe)2 treatment on Aß peptide-induced toxicity. Chronic exposure to (PhSe)2 attenuated oxidative stress induced by Aß1-42, with concomitant recovery of associative learning memory in C. elegans. Additionally, (PhSe)2 decreased Aß1-42 transgene expression, suppressed Aß1-42 peptide, and downregulated hsp-16.2 by reducing the need for this chaperone under Aß1-42-induced toxicity. These observations suggest that (PhSe)2 plays an important role in protecting against oxidative stress-induced toxicity, thus representing a promising pharmaceutical modality that attenuates Aß1-42 expression.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/antagonistas & inhibidores , Antioxidantes/administración & dosificación , Compuestos de Organoselenio/administración & dosificación , Fragmentos de Péptidos/antagonistas & inhibidores , Aldicarb/farmacología , Enfermedad de Alzheimer/psicología , Péptidos beta-Amiloides/metabolismo , Animales , Animales Modificados Genéticamente , Aprendizaje por Asociación/efectos de los fármacos , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/metabolismo , Inhibidores de la Colinesterasa/farmacología , Modelos Animales de Enfermedad , Proteínas de Choque Térmico/metabolismo , Actividad Motora/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fragmentos de Péptidos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA